Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISEDRONATE | 35MG | TABLET | Resolved | 2018-10-19 | 2018-12-21 | 64981 |
| APO-RISEDRONATE | 150MG | TABLET | Resolved | 2017-08-31 | 2017-10-20 | 20704 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-06-28 | 2017-12-01 | 14216 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-06-28 | 2017-11-30 | 14219 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-07-26 | 2017-11-29 | 17319 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-08-23 | 2017-11-29 | 20122 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-08-31 | 2017-11-30 | 20707 |
| APO-RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-05-14 | 2021-06-21 | 139422 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2021-05-14 | 2021-06-21 | 139425 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-06-04 | 2021-06-21 | 140428 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2021-07-16 | 2021-08-31 | 142687 |
| APO-RISPERIDONE | 4.0MG | TABLET | Resolved | 2019-10-09 | 2019-10-29 | 95882 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2019-12-12 | 2020-03-27 | 101097 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2020-01-22 | 2020-03-27 | 103920 |
| APO-RISPERIDONE | 3.0MG | TABLET | Resolved | 2020-06-10 | 2020-07-13 | 117407 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2025-01-30 | 2025-02-21 | 249089 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2020-08-06 | 2020-11-09 | 121913 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2020-10-14 | 2020-11-09 | 126314 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2020-10-14 | 2020-11-09 | 126317 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-02-19 | 2021-04-05 | 134442 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
| APO FUROSEMIDE TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
| APO FUROSEMIDE TAB 40MG | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
| APO FUROSEMIDE TAB 80MG | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
| APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
| APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
| APO HYDRO TAB 100MG | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO HYDRO TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
| APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
| APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
| APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
| APO METOPROLOL (TYPE L) TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
| APO METOPROLOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
| APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
| APO NAPROXEN TAB 250MG | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
| APO OXAZEPAM TAB 10MG | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
| APO OXAZEPAM TAB 15MG | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO OXAZEPAM TAB 30MG | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |